TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CGC

Canopy Growth Corp

Healthcare · Drug Manufacturers - Specialty & Generic

0.8845$ +1.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CGC
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
– +569.5% +214.2% +95.4% +190.4% +76.2% +37.1% -13.0% -29.9% -10.8% -9.5% +5.8%
– -959.7% – +66.0% +3,558.4% +213.3% +11.4% +38.2% -40.2% -45.5% -12.4% +13.4%
– +4,482.1% +103.9% +91.6% +19.9% -135.6% – -379.9% – – -1.7% -12.4%
– +351.6% +12.3% +79.4% +948.7% +305.6% -6.8% -44.0% -32.7% -78.8% -58.7% –
– +94.7% +119.2% +263.1% +385.8% +38.4% -47.3% -47.6% -7.0% -35.0% -41.7% -1.7%
– +166.6% +142.9% +189.9% +319.8% +154.8% -20.0% -36.6% +208.8% -87.9% -36.5% -27.4%
– – – – – – – – – – – –
– +112.7% -52.9% +1,087.9% +2,248.9% -63.5% +26.0% +1,128.8% +21.4% -16.5% -29.2% -48.8%
– – – – – – – – – – – –
– -91.1% +2,045.2% -114.5% – -3,057.5% – – – – -42.1% -99.7%
– – – – – – – – – – – –
– – -169.3% – – – – – – – – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?